The publication detail shows the title, authors (with indicators showing other profiled authors), information on the publishing organization, abstract and a link to the article in PubMed. This abstract is what is used to create the fingerprint of the publication. If any grants are referenced by the publication, they will be listed here as well.
Factors associated with hospitalization costs for patients with community-acquired pneumonia.
Sanjay Merchant; C Daniel Mullins; Ya-Chen Tina Shih (Profiled Author: C. Daniel Mullins)
University of Maryland, School of Pharmacy, Baltimore, Maryland, USA. email@example.com
Clinical therapeutics 2003;25(2):593-610.
BACKGROUND: Combined mortality rates for pneumonia and influenza suggest that the 2 conditions represent the sixth leading cause of death in the United States. The total cost of pneumonia, including indirect costs, was estimated to be approximately $23 billion per year in 1994. OBJECTIVE: The objective of this study was to assess variables that may be significantly associated with the cost of treating patients hospitalized with community-acquired pneumonia (CAP). We also assessed the impact of treatment guidelines for management of CAP (developed by managed care plans) on total costs. METHODS: Patients in 3 managed care plans who were hospitalized with a primary or secondary diagnosis of CAP in Maryland and Washington, DC, between January 1, 1997, and April 30, 1997, or between January 1, 1998, and April 30, 1998, were identified based on International Classification of Diseases, Ninth Revision codes. Clinical data were abstracted from patients' medical charts by nurses, and billing data were acquired from these plans. A retrospective data analysis was carried out using billing data from 3 managed care plans and clinical data from hospitals associated with the plans. A multivariate regression model was developed using the natural logarithm of cost as the dependent variable. Independent variables that were studied included severity of illness, days in the intensive care unit (ICU), triage per guidelines, drug therapy per guidelines, mortality, and managed care plan identifiers. RESULTS: The charts of 569 patients were assessed. The mean age of the study sample was 75.3 years. ICU days (P < 0.001), mortality, and drug therapy (both P < 0.01) per guidelines significantly affected costs. As expected, an increase in the number of ICU days led to an increase in costs. However, patients who received drug therapy recommended by the guidelines had significantly lower costs than patients not treated according to the guidelines (P = 0.001). CONCLUSIONS: The findings of this study suggest that guidelines for CAP management, such as those developed by managed care plans, may help reduce costs by minimizing unnecessary ICU admissions and appropriately managing patients with CAP.
This section shows information related to the publication - computed using the fingerprint of the publication - including related publications, related experts and related grants with fingerprints representing significant amounts of overlap between their fingerprint and this publication. The red dots indicate whether those experts or terms appear within the publication, thereby showing potential and actual connections.
Todd Gehr; Filitsa Bender; Jeffrey Fink; Paul Light; Karen Elliott; Christie Shield; Mary Turner; Cathy Mays; Joan Parrish; Nancy ArmisteadAdvances in peritoneal dialysis. Conference on Peritoneal Dialysis 2003;19():86-92.
Carl Asche; Carrie McAdam-Marx; Brian Seal; Benjamin Crookston; C Daniel MullinsThe Journal of antimicrobial chemotherapy 2008;61(5):1162-8.
C Daniel Mullins; Fadia T Shaya; Louis R Flowers; Elijah Saunders; Wallace Johnson; Winston WongClinical therapeutics 2004;26(2):285-93.
Appears in this Publication
Author of this Publication